<DOC>
	<DOCNO>NCT01951417</DOCNO>
	<brief_summary>This open-label , multi-center study conduct United States . The study examine change lesion count subject use Epiduo® Gel Pump ( daily ) conjunction Cetaphil® DermaControl™ Foam Wash ( twice daily ) Moisturizer SPF 30 ( daily ) . Subjects clinical diagnosis mild moderate acne eligible treatment Epiduo® accordance currently approve product label meet inclusion/exclusion criterion enrol study receive study product 8 week . Efficacy safety assessment include : complete lesion count , cutaneous irritation assessment , end study treatment questionnaire , photographic evaluation oiliness , skin tone , P Acnes , hydration assessment , barrier function assessment , treatment compliance , adverse event assessment .</brief_summary>
	<brief_title>Adapalene BPO Gel Pump , Moisturizer SPF 30 Foam Wash Patients With Mild Moderate Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Adapalene , Benzoyl Peroxide Drug Combination</mesh_term>
	<mesh_term>Adapalene</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>Men woman race , 9 year old , diagnosis mild moderate acne , eligible treatment adapalene BPO gel accordance currently approve product label . Subjects nodules cyst , pregnant breastfeeding , systemic dermatological disorder , topical condition facial hair could interfere evaluation .</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>